Skip to main content
SpringerLink
Log in

Determination of the Antiinfectious Activity of RU 41740 (Biostim) as an Example of an Immunomodulator

  • Chapter
Microbial Infections

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 319))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. Alfetra, A. Amoroso, G. M. Ferri, P. Basso, G. Guide, L. Bonomo, In vivo effects of RU41740 in aged humans: evaluation of some immunological parameters, Immunol. Clin. 7:39–45 (1988).

    Google Scholar 

  2. J. P. Andreux, M. Renard, and M. H. Andreux, Modulation of murine hemopoiesis by repeated injection of glycoprotein extract from klebsiella pneumoniae, Int. J. Immunopharmacol. 8:147–154 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. D. Anthoine, B. Blaive, G. Cabanieu, J. Chretien, A. Danrigal, C. H. Ducreuzet, D. Dusser, P. Leophonte, J. Migueres, J. F. Muir, and C. H. Ollagnier, Etude en double aveugle du Biostim dans la prevention des surinfections des patients atteints de bronchopathie chronique, Rev. Pneumol. Clin. 413:213–217 (1985).

    PubMed  CAS  Google Scholar 

  4. M. D. Anthonisen, M. D. Manfreda, C. P. W. Warren, E. S. Hershfield, G. K. M. Harding, and N. A. Nelson, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann. Intern. Med. 106:193–204 (1987).

    Google Scholar 

  5. D. M. Bamberger and B. L. Herndon, Bactericidal capacity of neutrophils in rabbits with experimental acute and chronic abscesses, J. Infect. Dis. 162:186–192, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. H. Blomgren, H. Viland, B. Cedermark, T. Theve, and U. Ohman, Oral treatment with RU41740 (Biostim) in patients with advanced colorectal cancer: influence on the blood lymphocyte population, Int. J. Immunopharmac. 2:71–76, 1989.

    Article  Google Scholar 

  7. J. Bonde, R. Dahl, R. Edeltein, A. Kok-Jensen, L. Lazer, L. PUnakivi, A. Seppala, U. Soes-Petersen, and K. Viskum, The effect of RU 41740 an immune modulating compound in the prevention of acute exacerbations in patients with chronic bronchitis, Eur. J. Respir. Dis. 69:235–241 (1986).

    PubMed  CAS  Google Scholar 

  8. P. Bonfils, Prophylaxie des infections des voies respiratoires chez l’enfant par le RU41740, Presse Med., 17:1430–1432 (1988).

    Google Scholar 

  9. C. Brambilla, Infections respiratoires recidivantes: definition des populations a risque et criteres d’evaluation dans les etudes d’efficacite de la prophylaxie, M/S, suppl. n°7:19–24 (1990).

    Google Scholar 

  10. F. Capsoni, F. Minonzio, E. Venegoni, A. M. Ongari, G. Guide and C. Zanussi, In vitro modulation of polymorphonuclear leukocyte functions by a glycoprotein extract from klebsiella pneumoniae (RU 41740): correction of corticosteroid-induced defects and phagocytosis and adherence, Int. J. Immunotherapy. IV 2: 107–115 (1988).

    Google Scholar 

  11. F. Capsoni, F. Minonzio, E. Venegoni, A. M. Ongari, P. L. Meroni, G. Guide, and C. Zanussi, In vitro and ex vivo effect of RU41740 on human polymorphonuclear leukeocyte fonction, Int. J. Immuno. 10:121–133 (1988).

    Article  CAS  Google Scholar 

  12. P. Carles, F. Fournial, R. Bollinelli, Interet du Biostim dans la prevention des episodes de surinfection chez les insuffisants respiratoires par bronchite chronique ou dilation des bronches, Gaz Med. France. 8825:1–3 (1981).

    Google Scholar 

  13. B. Chaumet, M. and Ch. Boissier, Structure et distribution du RU 41740, Presse Med. 17:1423–1425 (1988).

    PubMed  CAS  Google Scholar 

  14. N. V. Christou, I. Zakaluzny, J. C. Marshall, and C. W. Nohr, The effect of the immunomodulator RU 41740 (Biostim) on the specific and nonspecific immunosuppression induced by thermal injury of protein deprivation, Arch. Surg. 123:207–210 (1988).

    Article  PubMed  CAS  Google Scholar 

  15. J. P. Devlin and K. D. Hargrave, The design and synthesis of immune regulatory agents: targets and approaches. Tetrahedron 14:4327–4369 (1989).

    Article  Google Scholar 

  16. A. Fietta, C. Bersani, V. De Rose, A. Grassi, P. Mangiarotti, M. Uccelli, and C. Grassi, Evaluation of systemic host defense mechanisms in chronic bronchitis. Respiration 53:37–43 (1988).

    Article  PubMed  CAS  Google Scholar 

  17. A. Fietta, C. Bersani, V. De Rose, P. Mangiarotti, C. Merlini, M. Uccelli, G. Guidi, G. Gialdroni Grassi, Double-blind trial RU 41740 vs. placebo: immunological and clinical effects in a group of patients with chronic bronchitis. Respiration 54:145–152 (1988)

    Article  PubMed  CAS  Google Scholar 

  18. Fiszer-Szafarz, M. Rommain, C. Brossard, and P. Smets, Hyaluronic acid-degrading enzymes in rat alveolar macrophagesand in alveolar fluid: stimulation of enzyme activity after oral treatment with the immunomodulator RU 41740. Biology of the Cell 63: 355–360 (1988).

    PubMed  CAS  Google Scholar 

  19. M. Fortier, A. Bonfils, R. Zalisz, M. Heyman, and P. Smets, Pharmacokinetic profile of RU 41740, a bacterial immunomodulator, in mice, rats, and monkeys. Internatl. J. of Phamaceutics. 52:27–36 (1989).

    Article  CAS  Google Scholar 

  20. P. Gepner, Immunotolerance du RU 41740. Presse Med. 17:1458–1460 (1988).

    PubMed  CAS  Google Scholar 

  21. C. Griscelli, B. Rospierre, J. Montreuil, B. Fournet, G. Bruvier, J. M. Lang, C. Marchiani, R. Zalisz, and R. Edelstein, Pouvoir immunomodulateur de glycoproteines isolees de Klebsiella pneumoniae. In: Immunomodulation by microbial products and related compounds. Y. Yamamura and S. Kotani, ed., Proc. of an Internatl. Symp., Osaka, July 27–29, 1981, Amsterdam, Oxford, Princeton, Excerpta Medica 563:261–265 (1982).

    Google Scholar 

  22. M. Guenounou, F. Vacheron, R. Zalisz, P. Smets, and J. Agneray, Immunological activities of RU 41740, a glcoprotein extract from Klebsieela pneumoniae. I. Activation of murine B cells and induction of interleukin-1 production by macrophages. Ann. Immunol. (Inst. Pasteur) 135D:59–69 (1984).

    Article  CAS  Google Scholar 

  23. J. Herman, M. C. Kew, A. and A. R. Rabson, The effect of RU 41740 (Biostim) on the production of interleukin 1 by monocytes and enriched large granular lymphocytes in normals and patients with hepatocellular carcinoma. Cancer. Immunol. Immunother. 21a;26–30 (1986).

    Google Scholar 

  24. R. Fugonot, L. M. Gutierrez, and L. Hugonot, Action preventive des immunomo-dulateurs sur les infections respiratoires des sujets ages. Presse Med. 17:1445–1449 (1988).

    Google Scholar 

  25. V. Joly, Action d’un immunomodulateur, le RU 41740, sur les infections experimentales. Presse Med. 17:1430–1432 (1988).

    PubMed  CAS  Google Scholar 

  26. C. Lambre, J. C. Almayrac, A. Boussairi, A. Greffard, H. De Cremous, K. Atassi, and J. Bignon, Retentissement de l’administration d’un extrait de paroi de klebsiella pneumoniae sur l’immunite locale pulminaire. Rev. Mal. Resp. 6:R154–R194 (1989).

    Google Scholar 

  27. J. M. Lang, J. A. Gastaut, J. J. Sotto, J. Troncy, C. Marchiani, Enhancement of delayed cutaneous hypersensitivity by oral administration of RU 41740 (Biostim) in lymphoma patients. A randomized double blind multicentric trial. Int. J. Immunopharma. 8:687–690 (1986).

    Article  CAS  Google Scholar 

  28. G. Lenoir, Mucoviscidose. Encycl. Med. Chir (Paris-France) Poumons 6039 A95 9_188: 1-22.

    Google Scholar 

  29. F. Neukirch et al, La bronchite chronique. Rev. Mal. Resp. 5:331–346 (1988).

    CAS  Google Scholar 

  30. H. Nielsen, and J. Bonde, Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease. Eur. J. Respir. Dis. 68:200–206 (1986).

    PubMed  CAS  Google Scholar 

  31. Y. Pacheco, P. Fonlupt, M. Dubois, N. Biot, M. Perrin-Fayolle, and H. Pacheco, La methylation des phospholipides membranes du macrophage alveolaire dans la sarcoidose pulmonaire et les fibroses pulmonaires interstitielles diffuses. Pathol. Bio., 34,10:1067–1073 (1986).

    CAS  Google Scholar 

  32. M. L. Profeta, P. L. Meroni, G. Guidi, R. Palmieri, G. Palladino, V. Cantone, and C. Zanussi, Influenza vaccination with adjuvant RU 41740 in the elderly. Lancet April 25, 8539 1:973 (1987).

    Article  CAS  Google Scholar 

  33. A. Rudent, R. Zalisz, A. M. Quero, and P. Smets, Enhanced resistance of mice against influenza virus infection after local administration of glycoprotein extracts from klebsieela pneumoniae. In: J. Immunopharmacol. 7,4, 525–531 (1989).

    Article  Google Scholar 

  34. S. Sozzani, W. Luini, L. Braceschi, and F. Spreafico, The effect ofBiostim (RU 41740) on natural killer activity in different mouse organes. Int. J. Immuno-pharmacol. 8(8):845–853 (1986).

    Article  CAS  Google Scholar 

  35. F. Spreafico, Problems and challenges in the use of immunomodulating agents. Int. Arch. Allergy Appl. Immunol. 76, suppl. 1:108–111 (1985).

    Article  PubMed  CAS  Google Scholar 

  36. J. R. Viallat, C. Boutin, P. Farisse, and D. Constantini, Etude en double aveugle d’un immunomodulateur d’origin bacterienne (Biostim) dans la prevention des episodes infectieux chez le bronchitique chronique. Poumon Coeur 39:53–57 (1983).

    PubMed  CAS  Google Scholar 

  37. C. Wood, and G. Moller, Influence of RU 41740, a glcoprotein extract from klebsielle pneumoniae, on the murine immune system. KK. II. RU 41740 facilitates the responses to Con A in otherwise unresponsive T. enriched cells. J. Immunol. 125(1):131–136 (1985).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CASSENNE Laboratories, Tour Roussel Hoechst 1 Terrasse Bellini, 92080, Puteaux, France

    I. Ounis

Authors
  1. I. Ounis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of South Florida, Tampa, Florida, USA

    Herman Friedman  & Thomas W. Klein  & 

  2. Teikyo University School of Medicine, Tokyo, Japan

    Hideyo Yamaguchi

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ounis, I. (1992). Determination of the Antiinfectious Activity of RU 41740 (Biostim) as an Example of an Immunomodulator. In: Friedman, H., Klein, T.W., Yamaguchi, H. (eds) Microbial Infections. Advances in Experimental Medicine and Biology, vol 319. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3434-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3434-1_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6519-8

  • Online ISBN: 978-1-4615-3434-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation